Ignite Creation Date:
2025-12-24 @ 1:51 PM
Ignite Modification Date:
2026-01-17 @ 11:51 PM
Study NCT ID:
NCT04426695
Status:
COMPLETED
Last Update Posted:
2023-01-27
First Post:
2020-06-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19
Sponsor:
Regeneron Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
R10933-10987-COV-2066
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None